South America Real-world Evidence (RWE) Solutions Market Size and YoY Growth (2025–2032)

Strategic use of real-world data is becoming a core pillar for healthcare planning and life sciences decision-making across emerging economies. In 2025, the South America Real-world Evidence (RWE) Solutions Market was valued at USD 191.98 million, supported by growing regulatory openness, expanding clinical databases, and increased adoption by pharmaceutical and biotech companies. In 2026, the market is estimated to reach USD 211.75 million as investments rise in data integration platforms and outcomes-focused research initiatives. Over the forecast period, the South America Real-world Evidence (RWE) Solutions Market is projected to reach USD 441.92 million by 2032, reflecting wider institutional adoption across payers, providers, and public health authorities. A YoY growth rate of 15.65% by the end of the period highlights strengthening analytics capability and improved data governance frameworks across key economies. These developments support evidence-based policy formulation, enhance clinical and economic evaluation, and position South America as a steadily advancing participant in the global real-world evidence solutions landscape.